Development and optimization of baicalin-loaded solid lipid nanoparticles prepared by coacervation method using central composite design

被引:166
作者
Hao, Jifu [1 ,2 ]
Wang, Fugang [2 ]
Wang, Xiaodan [2 ]
Zhang, Dianrui [1 ]
Bi, Yanping [2 ]
Gao, Yunsheng [2 ]
Zhao, Xuemei [2 ]
Zhang, Qiang [3 ]
机构
[1] Shandong Univ, Coll Pharm, Dept Pharmaceut, Jinan 250012, Peoples R China
[2] Taishan Med Univ, Coll Pharm, Tai An 271016, Shandong, Peoples R China
[3] Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Beijing 100083, Peoples R China
关键词
Baicalin; Coacervation method; Central composite design; Solid lipid nanoparticle; CYCLOSPORINE-A; DRUG-DELIVERY; IN-VITRO; SLN; PHARMACOKINETICS; FORMULATION; ABSORPTION; QUALITY; RELEASE; VIVO;
D O I
10.1016/j.ejps.2012.07.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The objective of this study was to design and optimize a novel baicalin-loaded solid lipid nanoparticles (SLNs) carrier system composed of a stearic acid alkaline salt as lipid matrix and prepared as per the coacervation method in which fatty acids precipitated from their sodium salt micelles in the presence of polymeric nonionic surfactants. A two-factor five-level central composite design (CCD) was introduced to perform the experiments. A quadratic polynomial model was generated to predict and evaluate the independent variables with respect to the dependent variables. The composition of optimal formulation was determined as 0.69% (w/v) lipid and 26.64% (w/w) drug/lipid ratio. The results showed that the optimal formulation of baicalin-loaded SLN had entrapment efficiency (EE) of 88.29%, particle size of 347.3 nm and polydispersity index (PDI) of 0.169. The morphology of nanoparticles was found to be nearly spherical in shape by scanning electron microscopy (SEM) observation. The differential scanning calorimetry (DSC) analysis indicated that the drug incorporated into SLN was not in an amorphous form but in a crystalline state. The C-max MRT, AUMC(0 ->infinity) and AUC(0 ->infinity) values of SLN were approximately 1.6-fold, 1.9-fold, 5.0-fold and 2.6-fold greater than that of reference preparation, respectively. (c) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:497 / 505
页数:9
相关论文
共 31 条
[1]   Balicalin, the predominant flavone glucuronide of scutellariae radix, is absorbed from the rat gastrointestinal tract as the aglycone and restored to its original form [J].
Akao, T ;
Kawabata, K ;
Yanagisawa, E ;
Ishihara, K ;
Mizuhara, Y ;
Wakui, Y ;
Sakashita, Y ;
Kobashi, K .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2000, 52 (12) :1563-1568
[2]  
Attama Anthony A, 2011, Recent Pat Drug Deliv Formul, V5, P178
[3]  
Battaglia L, 2011, NANOMEDICINE-UK, V6, P1561, DOI [10.2217/nnm.11.52, 10.2217/NNM.11.52]
[4]   Solid lipid nanoparticles produced through a coacervation method [J].
Battaglia, Luigi ;
Gallarate, Marina ;
Cavalli, Roberta ;
Trotta, Michele .
JOURNAL OF MICROENCAPSULATION, 2010, 27 (01) :78-85
[5]   Amphotericin B loaded SLN prepared with the coacervation technique [J].
Bianco, M. A. ;
Gallarate, M. ;
Trotta, M. ;
Battaglia, L. .
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2010, 20 (03) :187-191
[6]  
Corrias Francesco, 2011, Recent Pat Drug Deliv Formul, V5, P201
[7]   D-optimal mixture design: Optimization of ternary matrix blends for controlled zero-order drug release from oral dosage forms [J].
El-Malah, Yasser ;
Nazzal, Sami ;
Khanfar, Nile M. .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2006, 32 (10) :1207-1218
[8]   Issues in oral nanoparticle drug carrier uptake and targeting [J].
Florence, AT .
JOURNAL OF DRUG TARGETING, 2004, 12 (02) :65-70
[9]   Cisplatin-loaded SLN produced by coacervation technique [J].
Gallarate, M. ;
Trotta, M. ;
Battagha, L. ;
Chirio, D. .
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2010, 20 (05) :343-347
[10]   Cyclosporine A loaded SLNs: Evaluation of cellular uptake and corneal cytotoxicity [J].
Gokce, Evren H. ;
Sandri, Giuseppina ;
Bonferoni, M. Cristina ;
Rossi, Silvia ;
Ferrari, Franca ;
Guneri, Tamer ;
Caramella, Carla .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 364 (01) :76-86